APA (7th ed.) Citation

Hassel, J. C., Enk, A., Naoum, C., Reiser, S., & Gauss, A. (2025). Tofacitinib for treatment of a cortisone, mycophenolate mofetil and infliximab-refractory immune checkpoint inhibitor-mediated colitis in an advanced melanoma patient. European journal of cancer, 227, . https://doi.org/10.1016/j.ejca.2025.115690

Chicago Style (17th ed.) Citation

Hassel, Jessica C., Alexander Enk, Christina Naoum, Sophie Reiser, and Annika Gauss. "Tofacitinib for Treatment of a Cortisone, Mycophenolate Mofetil and Infliximab-refractory Immune Checkpoint Inhibitor-mediated Colitis in an Advanced Melanoma Patient." European Journal of Cancer 227 (2025). https://doi.org/10.1016/j.ejca.2025.115690.

MLA (9th ed.) Citation

Hassel, Jessica C., et al. "Tofacitinib for Treatment of a Cortisone, Mycophenolate Mofetil and Infliximab-refractory Immune Checkpoint Inhibitor-mediated Colitis in an Advanced Melanoma Patient." European Journal of Cancer, vol. 227, 2025, https://doi.org/10.1016/j.ejca.2025.115690.